6
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T6229 | Daclatasvir | Daklinza,EBP 883,BMS-790052 | HCV Protease |
Daclatasvir (EBP 883) (BMS-790052) is a highly selective inhibitor of HCV NS5A with EC50 of 9-50 pM, for a broad range of HCV replicon genotypes and the JFH-1 genotype 2a infectious virus in cell culture. Phase 3. | |||
T1786 | Daclatasvir dihydrochloride | BMS-790052 dihydrochloride | HCV Protease |
Daclatasvir dihydrochloride (BMS-790052 dihydrochloride) is an orally available antiviral agent that inhibits the NS5A region of the hepatitis C virus (HCV) and is used in combination with other oral antiviral agents to ... | |||
T37915 | Monodes(N-carboxymethyl)valine Daclatasvir | ||
Monodes(N-carboxymethyl)valine Daclatasvir, also known as Daclatasvir Impurity A, is the principal degradation product of Daclatasvir.Daclatasvir is a potent inhibitor of the HCV NS5A protein[1]. | |||
T74007 | Daclatasvir Impurity C | ||
Daclatasvir Impurity C is an impurity found in Daclatasvir, a robust inhibitor of the HCV NS5A protein [1]. | |||
T74006 | Daclatasvir Impurity B | ||
Daclatasvir Impurity B, a noted impurity of the antiviral agent Daclatasvir, acts as a potent inhibitor of the HCV NS5A protein [1]. | |||
T73223 | NS5A-IN-3 | HCV Protease | |
NS5A-IN-3 (Compound 15) serves as a potent NS5A inhibitor, displaying exceptionally high efficacy against HCV genotype 1b, enhanced activity towards genotype 3a (GT 3a), and substantial metabolic stability. It also demon... |